Table 5. Comparison of Subsequent Thrombotic Events According to Antiplatelet Therapy/Anticoagulation among Patients with Definite APS.
| Antiplatelet agent (n = 22) | Anticoagulation (n = 24) | Total (n = 46) | Unadjusted | ||
|---|---|---|---|---|---|
| HR (95% CI) | p value | ||||
| Recurrence of any thrombotic events | 6 (27.3%) | 8 (33.3%) | 14 (30.4%) | 0.992 (0.341–2.891) | 0.989 |
APS, antiphospholipid syndrome; HR, hazard ratio; CI, confidence interval.